Literature DB >> 25200283

Noncoding RNAs and myocardial fibrosis.

Thomas Thum1.   

Abstract

Cardiac stress leads to remodelling of cardiac tissue, which often progresses to heart failure and death. Part of the remodelling process is the formation of fibrotic tissue, which is caused by exaggerated activity of cardiac fibroblasts leading to excessive extracellular matrix production within the myocardium. Noncoding RNAs (ncRNAs) are a diverse group of endogenous RNA-based molecules, which include short (∼22 nucleotides) microRNAs and long ncRNAs (of >200 nucleotides). These ncRNAs can regulate important functions in many cardiovascular cells types. This Review focuses on the role of ncRNAs in cardiac fibrosis; specifically, ncRNAs as therapeutic targets, factors for direct fibroblast transdifferentation, their use as diagnostic and prognostic markers, and their potential to function as paracrine modulators of cardiac fibrosis and remodelling.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25200283     DOI: 10.1038/nrcardio.2014.125

Source DB:  PubMed          Journal:  Nat Rev Cardiol        ISSN: 1759-5002            Impact factor:   32.419


  106 in total

1.  MicroRNA-101 inhibited postinfarct cardiac fibrosis and improved left ventricular compliance via the FBJ osteosarcoma oncogene/transforming growth factor-β1 pathway.

Authors:  Zhenwei Pan; Xuelin Sun; Hongli Shan; Ning Wang; Jinghao Wang; Jinshuai Ren; Shuya Feng; Liangjun Xie; Chunying Lu; Ye Yuan; Yang Zhang; Ying Wang; Yanjie Lu; Baofeng Yang
Journal:  Circulation       Date:  2012-07-18       Impact factor: 29.690

Review 2.  Regulatory RNAs and paracrine networks in the heart.

Authors:  Janika Viereck; Claudia Bang; Ariana Foinquinos; Thomas Thum
Journal:  Cardiovasc Res       Date:  2014-02-21       Impact factor: 10.787

3.  Role of miR-21 in the pathogenesis of atrial fibrosis.

Authors:  Oliver Adam; Björn Löhfelm; Thomas Thum; Shashi K Gupta; Sarah-Lena Puhl; Hans-Joachim Schäfers; Michael Böhm; Ulrich Laufs
Journal:  Basic Res Cardiol       Date:  2012-07-04       Impact factor: 17.165

Review 4.  Exosomes and cardiac repair after myocardial infarction.

Authors:  Susmita Sahoo; Douglas W Losordo
Journal:  Circ Res       Date:  2014-01-17       Impact factor: 17.367

5.  MicroRNA29: a mechanistic contributor and potential biomarker in atrial fibrillation.

Authors:  Kristin Dawson; Reza Wakili; Balázs Ordög; Sebastian Clauss; Yu Chen; Yuki Iwasaki; Niels Voigt; Xiao Yan Qi; Moritz F Sinner; Dobromir Dobrev; Stefan Kääb; Stanley Nattel
Journal:  Circulation       Date:  2013-03-04       Impact factor: 29.690

6.  Induction of human cardiomyocyte-like cells from fibroblasts by defined factors.

Authors:  Rie Wada; Naoto Muraoka; Kohei Inagawa; Hiroyuki Yamakawa; Kazutaka Miyamoto; Taketaro Sadahiro; Tomohiko Umei; Ruri Kaneda; Tomoyuki Suzuki; Kaichiro Kamiya; Shugo Tohyama; Shinsuke Yuasa; Kiyokazu Kokaji; Ryo Aeba; Ryohei Yozu; Hiroyuki Yamagishi; Toshio Kitamura; Keiichi Fukuda; Masaki Ieda
Journal:  Proc Natl Acad Sci U S A       Date:  2013-07-16       Impact factor: 11.205

7.  Inhibition of microRNA-92a protects against ischemia/reperfusion injury in a large-animal model.

Authors:  Rabea Hinkel; Daniela Penzkofer; Stefanie Zühlke; Ariane Fischer; Wira Husada; Quan-Fu Xu; Elisabeth Baloch; Eva van Rooij; Andreas M Zeiher; Christian Kupatt; Stefanie Dimmeler
Journal:  Circulation       Date:  2013-07-29       Impact factor: 29.690

Review 8.  ESC Working Group on Myocardial Function Position Paper: how to study the right ventricle in experimental models.

Authors:  Adelino F Leite-Moreira; André P Lourenço; Jean-Luc Balligand; Johann Bauersachs; Angela Clerk; Leon J De Windt; Stephane Heymans; Denise Hilfiker-Kleiner; Emilio Hirsch; Guido Iaccarino; Karol A Kaminski; Ralph Knöll; Manuel Mayr; Guido Tarone; Thomas Thum; Carlo G Tocchetti
Journal:  Eur J Heart Fail       Date:  2014-02-23       Impact factor: 15.534

9.  Macrophage microRNA-155 promotes cardiac hypertrophy and failure.

Authors:  Stephane Heymans; Maarten F Corsten; Wouter Verhesen; Paolo Carai; Rick E W van Leeuwen; Kevin Custers; Tim Peters; Mark Hazebroek; Lauran Stöger; Erwin Wijnands; Ben J Janssen; Esther E Creemers; Yigal M Pinto; Dirk Grimm; Nina Schürmann; Elena Vigorito; Thomas Thum; Frank Stassen; Xiaoke Yin; Manuel Mayr; Leon J de Windt; Esther Lutgens; Kristiaan Wouters; Menno P J de Winther; Serena Zacchigna; Mauro Giacca; Marc van Bilsen; Anna-Pia Papageorgiou; Blanche Schroen
Journal:  Circulation       Date:  2013-08-16       Impact factor: 29.690

10.  A signature of circulating microRNAs differentiates takotsubo cardiomyopathy from acute myocardial infarction.

Authors:  Milosz Jaguszewski; Julia Osipova; Jelena-Rima Ghadri; Lars Christian Napp; Christian Widera; Jennifer Franke; Marcin Fijalkowski; Radoslaw Nowak; Marta Fijalkowska; Ingo Volkmann; Hugo A Katus; Kai C Wollert; Johann Bauersachs; Paul Erne; Thomas F Lüscher; Thomas Thum; Christian Templin
Journal:  Eur Heart J       Date:  2013-09-17       Impact factor: 29.983

View more
  64 in total

Review 1.  Long noncoding RNAs in cardiac development and ageing.

Authors:  Yvan Devaux; Jennifer Zangrando; Blanche Schroen; Esther E Creemers; Thierry Pedrazzini; Ching-Pin Chang; Gerald W Dorn; Thomas Thum; Stephane Heymans
Journal:  Nat Rev Cardiol       Date:  2015-04-07       Impact factor: 32.419

2.  Interleukin-10 Inhibits Bone Marrow Fibroblast Progenitor Cell-Mediated Cardiac Fibrosis in Pressure-Overloaded Myocardium.

Authors:  Suresh K Verma; Venkata N S Garikipati; Prasanna Krishnamurthy; Sarah M Schumacher; Laurel A Grisanti; Maria Cimini; Zhongjian Cheng; Mohsin Khan; Yujia Yue; Cindy Benedict; May M Truongcao; Joseph E Rabinowitz; David A Goukassian; Douglas Tilley; Walter J Koch; Raj Kishore
Journal:  Circulation       Date:  2017-06-30       Impact factor: 29.690

Review 3.  [Non-coding RNA : Innovative regulators with therapeutic perspective].

Authors:  A Bührke; C Bär; T Thum
Journal:  Herz       Date:  2018-03       Impact factor: 1.443

4.  Cardiac fibroblasts: from origin to injury.

Authors:  Michelle D Tallquist
Journal:  Curr Opin Physiol       Date:  2017-12-13

Review 5.  MicroRNAs in placental health and disease.

Authors:  Jean-François Mouillet; Yingshi Ouyang; Carolyn B Coyne; Yoel Sadovsky
Journal:  Am J Obstet Gynecol       Date:  2015-10       Impact factor: 8.661

6.  lncITPF Promotes Pulmonary Fibrosis by Targeting hnRNP-L Depending on Its Host Gene ITGBL1.

Authors:  Xiaodong Song; Pan Xu; Chao Meng; Chenguang Song; Timothy S Blackwell; Rongrong Li; Hongbo Li; Jinjin Zhang; Changjun Lv
Journal:  Mol Ther       Date:  2018-09-06       Impact factor: 11.454

7.  Dawn of the Epi-LncRNAs: new path from Myheart.

Authors:  Zhihua Wang; Yibin Wang
Journal:  Circ Res       Date:  2015-01-16       Impact factor: 17.367

Review 8.  Non-coding RNAs in cardiovascular diseases: diagnostic and therapeutic perspectives.

Authors:  Wolfgang Poller; Stefanie Dimmeler; Stephane Heymans; Tanja Zeller; Jan Haas; Mahir Karakas; David-Manuel Leistner; Philipp Jakob; Shinichi Nakagawa; Stefan Blankenberg; Stefan Engelhardt; Thomas Thum; Christian Weber; Benjamin Meder; Roger Hajjar; Ulf Landmesser
Journal:  Eur Heart J       Date:  2018-08-01       Impact factor: 29.983

Review 9.  Prospective and therapeutic screening value of non-coding RNA as biomarkers in cardiovascular disease.

Authors:  Albert Busch; Suzanne M Eken; Lars Maegdefessel
Journal:  Ann Transl Med       Date:  2016-06

Review 10.  Diabetes-associated cardiac fibrosis: Cellular effectors, molecular mechanisms and therapeutic opportunities.

Authors:  Ilaria Russo; Nikolaos G Frangogiannis
Journal:  J Mol Cell Cardiol       Date:  2015-12-15       Impact factor: 5.000

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.